导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -7.01% | 3579/4982 |
| 近一周 | -5.10% | 5117/5419 |
| 近一月 | 3.75% | 74/5423 |
| 近一季 | -3.68% | 1615/5358 |
| 近半年 | -36.94% | 5113/5131 |
| 近一年 | -9.87% | 3599/4733 |
| 近两年 | 1.26% | 4037/4208 |
| 近三年 | -3.30% | 3130/3661 |
| 成立以来 | 53.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
26.90% 7/5130 |
-37.85% 5095/5464 |
- - |
- - |
| 2025 | -9.64% 4451/5130 |
-1.30% 3997/4624 |
0.97% 2815/4802 |
-5.66% 4739/4970 |
-3.88% 3234/5130 |
| 2024 | 32.26% 57/4618 |
14.58% 31/4340 |
-4.31% 2889/4442 |
40.73% 1/4550 |
-14.29% 4494/4618 |
| 2023 | -11.30% 1249/4216 |
29.84% 13/3759 |
-4.47% 1998/3909 |
-15.27% 3399/4055 |
-15.60% 4021/4209 |
| 2022 | -32.88% 2497/3578 |
-9.43% 282/2804 |
-1.06% 2669/3205 |
-23.42% 3147/3430 |
-2.19% 2000/3570 |
| 2021 | 12.37% 554/2717 |
0.69% 296/1745 |
-5.26% 1730/2232 |
10.71% 187/2560 |
6.40% 513/2708 |
| 2020 | 32.59% 808/1596 |
-6.21% 795/1036 |
18.78% 749/1256 |
8.14% 822/1472 |
10.06% 1065/1690 |
| 2019 | 31.46% 540/926 |
21.55% 1249/3054 |
-4.41% 2467/3201 |
3.69% 593/939 |
9.11% 443/1014 |
| 2018 | -16.07% 78/668 |
- - |
- - |
- - |
-5.44% 1275/2977 |
| 2017 | 4.22% 346/531 |
- - |
- - |
- - |
- - |
| 2016 | -6.36% 101/455 |
- - |
- - |
- - |
- - |
| 2015 | -4.70% 404/433 |
- - |
- - |
- - |
- - |
| 2014 | 14.75% 309/432 |
- - |
- - |
- - |
- - |
| 2013 | 17.63% 157/398 |
- - |
- - |
- - |
- - |
| 2012 | -3.80% 426/459 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 0.9797 | 54.69% |
| 招商创新增长混合A | 1.0526 | 54.25% |
| 招商创新增长混合C | 1.0013 | 53.96% |
| 华泰柏瑞医疗健康A | 2.5834 | 49.29% |
| 招商品质成长混合A | 1.0196 | 49.15% |
| 大摩优悦安和混合A | 0.8851 | 47.23% |
| 大摩优悦安和混合C | 0.8688 | 47.08% |
| 华泰柏瑞医疗健康C | 2.5230 | 44.21% |
| 大摩健康产业混合A | 1.9140 | 32.70% |
| 中信建投医药健康A | 0.7640 | 31.75% |
| 西部利得策略优选混合A VS. 长安宏观策略混合A(740001) |